Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

RYAH Group Inc. (CSE: RYAH) Devices Ideal for Implementation of New Cannabis Intake Control Recommendations

Research team uses Delphi process for the first time to identify ideal cannabis dosing guidelines. After several rounds of voting, the ‘global task force’ created three separate dosing protocols. RYAH Group’s suite of precision dosing devices provide a practical way to safely execute these — or any — recommended dosing guidelines. Dosing recommendations are critical […]

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Lining Things Up for a Successful Rest of the Year, 2021

PlantX has made important moves recently, including additions to its Board of Directors, and the decision to commence an NCIB to repurchase up to 5% of its common shares Going forward, the company plans to sustain its ongoing retail branding initiative-renaming existing brick-and-mortar stores as “XMarket” Physical stores in British Columbia, Squamish, and Venice Beach, […]

FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Shares Progress Update, Corporate Presentation, with Investors at H.C. Wainwright Conference

The company has completed many milestones to date, with plans to finalize its Phase 2 Hydrogen-Ammonia Synthesizer commercial prototype by the end of 2021, and other high-visibility projects planned for 2022 Hydrogen transportation and storage poses a problem on account of volatility and high costs, but carbon-free ammonia is a cost-efficient and environmentally logical alternative […]

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) POC Lab Test Ecosystem Rollout Advances Fight Against COVID, Flu, RSV, Chronic Conditions

Health diagnostics technology innovator Avricore Health has introduced its HealthTab platform as a means of improving patients’ ability to monitor their health conditions through point-of-care testing under the guidance of trained pharmacists HealthTab uses partnerships with molecular testing device makers to establish rapid molecular testing services in pharmacies, including the Shoppers Drug Mart pharmacy network […]

Sugarmade Inc. (SGMD) Ideally Positioned in Billion-Dollar Space ‘Ripe for Cannabis Delivery’

States that have already legalized cannabis are seeing a spike in business thanks to the overwhelming convenience of cannabis delivery Article reports that delivery services can “help surge revenue for retailers that jump in to take advantage” Earlier this year, SGMD launched a new business initiative for the licensed delivery of cannabis products According to […]

FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Phase Two Growth Plans, CEO Interview on Gamechangers LIVE

FuelPositive announced four new appointments – Nelson Leite and Olushola Ashiru have joined the Board, while Francois Desloges and Jennifer Spencer have been appointed to the Executive Leadership Team The appointments are in a move to actualize Phase Two of the company’s Hydrogen-Ammonia Synthesizer commercial prototype system, critical to its future growth FuelPositive’s CEO expressed […]

Nemaura Medical Inc. (NASDAQ: NMRD) Is ‘One to Watch’

Nemaura’s flagship product, sugarBEAT(R), is a wearable, non-invasive and flexible Continuous Glucose Monitor (“CGM”) designed for people with diabetes and prediabetes sugarBEAT received CE mark clearance in May 2019, allowing it to be marketed and sold within the European Union, and Nemaura has submitted a premarket approval application to the U.S. FDA Nemaura continues to […]

InMed Pharmaceuticals Inc. (NASDAQ: INM) Signs Definitive Agreement to Acquire 100% of BayMedica Inc., Positioning it to Stand Distinct in Rare Cannabinoids Manufacturing, Become a Revenue-Generating Company, Expand Drug Development Capabilities

InMed Pharmaceuticals recently announced it has entered a definitive agreement to acquire 100% of BayMedica Inc. BayMedica is a private company that specializes in the manufacture and commercialization of rare cannabinoids Upon closing, the transaction will make InMed a global leader in the manufacturing of rare cannabinoids in addition to transforming it into a revenue-generating […]

 

From Our Blog

Surgeon, Payer, Patient Win: The Economic and Workflow Advantages Positioning GelrinC as a New Standard of Care for Knee Cartilage Repair

August 5, 2026

Regentis Biomaterials Ltd. (NYSE American: RGNT) is advancing GelrinC, its innovative cell-free hydrogel implant for focal knee cartilage repair, with a value proposition that extends across the entire healthcare ecosystem. Designed to simplify treatment while improving clinical outcomes, GelrinC offers meaningful benefits for surgeons, patients, and healthcare payers alike. Recent European regulatory approval for a […]

Rotate your device 90° to view site.